tertensif

Medicinal product

(Invented) name

tertensif

Active substance (s)

Indapamidas

Strength

2,5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C03BA11, Indapamide

Marketing authorisation holder

Les Laboratoires Servier, Prancūzija

Date of authorisation

1994-07-05

Date of renewal

2007-11-30

Documents

0939 Pakuotės lapelis 2021 11 18.docx

0939 tertensif 2,5mg tab PCS PL 2021 11 18.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Indapamidas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
5187	10480	1010480	lizdinė plokštelė	N30		Receptinis	LT/1/94/0939/001	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2007-11-30	Perregistruotas
1994-07-05	Registruotas